Review Evaluates SLC7A11 Ferroptosis Pathways in BRCA1-Mutant Breast Cancer
A review evaluates the SLC7A11-ferroptosis axis in BRCA1-mutant breast cancer, highlighting preclinical therapeutic potential alongside critical gaps in resistance mechanisms.
